enGene Therapeutics (ENGN) Cash & Current Investments (2022 - 2026)
enGene Therapeutics (ENGN) posted Cash & Current Investments of $266.32 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 31.9% from $201.91 million a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Cash & Current Investments came in at $193.74 million, down 18.7% from FY2024.
- Annual Cash & Current Investments shows a three-year compound annual growth rate of 111.7% (FY2022 to FY2025).
- In prior fiscal years, enGene Therapeutics' Cash & Current Investments was $238.33 million in FY2024 (+192.4%), $81.52 million in FY2023 (+298.9%) and $20.43 million in FY2022.
- Quarterly Cash & Current Investments has run from a low of $20.43 million in fiscal Q4 2022 to a high of $275.95 million in fiscal Q1 2026 over five years.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with growth averaging 45.4% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was fiscal Q4 2023, with growth of 298.9%; the weakest was fiscal Q3 2025, with a decline of 21.6%.
- According to Business Quant data, Cash & Current Investments for the three prior fiscal quarters was $258.47 million (Q2 2026), $275.95 million (Q1 2026) and $193.74 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 14.27 Bn |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | 266.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 266.32 Mn |
| Apr 30, 2026 | 258.47 Mn |
| Jan 31, 2026 | 275.95 Mn |
| Oct 31, 2025 | 193.74 Mn |
| Jul 31, 2025 | 201.91 Mn |
| Apr 30, 2025 | 217.39 Mn |
| Jan 31, 2025 | 213.81 Mn |
| Oct 31, 2024 | 238.33 Mn |
| Jul 31, 2024 | 257.68 Mn |
| Apr 30, 2024 | 264.81 Mn |
| Jan 31, 2024 | 85.65 Mn |
| Oct 31, 2023 | 81.52 Mn |
| Oct 31, 2022 | 20.43 Mn |
API Access
enGene Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();